Filtered By:
Condition: Cholesterol
Management: Insurance

This page shows you your search results in order of date.

Order by Relevance | Date

Total 158 results found since Jan 2013.

COVID-19 ’ s Impact on Heart Health Still Confounds Doctors
(ST. LOUIS) — Firefighter and paramedic Mike Camilleri once had no trouble hauling heavy gear up ladders. Now battling long COVID, he gingerly steps onto a treadmill to learn how his heart handles a simple walk. “This is, like, not a tough-guy test so don’t fake it,” warned Beth Hughes, a physical therapist at Washington University in St. Louis. [time-brightcove not-tgx=”true”] Somehow, a mild case of COVID-19 set off a chain reaction that eventually left Camilleri with dangerous blood pressure spikes, a heartbeat that raced with slight exertion, and episodes of intense chest pain...
Source: TIME: Health - August 10, 2023 Category: Consumer Health News Authors: Lauran Needgaard/ Associated Press Tags: Uncategorized COVID-19 healthscienceclimate wire Source Type: news

Rate of Change in 10-Year Atherosclerotic Cardiovascular Disease Risk and Its Implications for Primary Prevention
CONCLUSIONS: The temporal change in 10-year ASCVD risk over a period of 4 to 5 years reflects success or failure in controlling major cardiovascular risk factors and indicates the risk of future ASCVD events. The ∆10-year ASCVD risk/year can be used as an indicator of primary prevention and guide the application of preventive measures.PMID:37470768 | DOI:10.1161/HYPERTENSIONAHA.122.20678
Source: Atherosclerosis - July 20, 2023 Category: Cardiology Authors: In-Chang Hwang Chee Hae Kim Jae-Young Kim Hong-Mi Choi Yeonyee E Yoon Goo-Yeong Cho Source Type: research

Contemporary Treatment and Outcome of Patients with Ischaemic Lower Limb Amputation: A Focus on Sex Differences
CONCLUSION: Patients undergoing ischaemic LLA still have a poor prognosis marked by high rates of recurrent cardiovascular and limb events resulting in > 50% mortality within two years. The continuous lack of guideline recommended therapies, particularly in women, may be associated with the persisting poor outcome, necessitating urgent further investigation.PMID:37355161 | DOI:10.1016/j.ejvs.2023.06.018
Source: PubMed: Eur J Vasc Endovasc ... - June 24, 2023 Category: Surgery Authors: Lena Makowski Christiane Engelbertz Jeanette K öppe Patrik Dr öge Thomas Ruhnke Christian G ünster Joachim Ger ß Eva Freisinger Nasser Malyar Holger Reinecke Jannik Feld Source Type: research

Recurrent Atherosclerotic Cardiovascular Disease Events Potentially Prevented with Guideline-Recommended Cholesterol-Lowering Therapy following Myocardial Infarction
ConclusionImplementation of guideline-recommended cholesterol-lowering therapy could prevent a substantial percentage of recurrent ASCVD events.
Source: Cardiovascular Drugs and Therapy - April 13, 2023 Category: Cardiology Source Type: research

Association between Low-Density Lipoprotein Cholesterol Level and Cardiovascular Outcomes in Korean Adults: A Nationwide Cohort Study
CONCLUSION: We confirmed the incidence of CVD was increased in higher LDL-C range. The risk of CVD increased from ≥70 mg/dL of LDL-C in very high-risk and high-risk groups, and from ≥130 mg/dL of LDL-C in moderate-risk and low-risk groups in Korean adults.PMID:36727164 | DOI:10.4093/dmj.2021.0320
Source: Diabetes and Metabolism Journal - February 2, 2023 Category: Endocrinology Authors: Junghyun Noh Min Kyong Moon Eun-Jung Rhee Sang Hyun Park Hyeon Chang Kim Byung Jin Kim Hae Jin Kim Seonghoon Choi Jin Oh Na Young Youl Hyun Bum Joon Kim Kyung-Do Han In-Kyung Jeong Source Type: research

Cardiovascular Outcomes according to Comorbidities and Low-Density Lipoprotein Cholesterol in Korean People with Type 2 Diabetes Mellitus
CONCLUSION: For primary prevention of CVD in Korean adults with T2DM, it can be helpful to lower LDL-C targets when there are chronic kidney disease, HT, a long duration of diabetes mellitus, or three or more CV risk factors.PMID:36727163 | DOI:10.4093/dmj.2021.0344
Source: Diabetes and Metabolism Journal - February 2, 2023 Category: Endocrinology Authors: Min Kyong Moon Junghyun Noh Eun-Jung Rhee Sang Hyun Park Hyeon Chang Kim Byung Jin Kim Hae Jin Kim Seonghoon Choi Jin Oh Na Young Youl Hyun Bum Joon Kim Kyung-Do Han In-Kyung Jeong Source Type: research

Association between Low-Density Lipoprotein Cholesterol Level and Cardiovascular Outcomes in Korean Adults: A Nationwide Cohort Study
CONCLUSION: We confirmed the incidence of CVD was increased in higher LDL-C range. The risk of CVD increased from ≥70 mg/dL of LDL-C in very high-risk and high-risk groups, and from ≥130 mg/dL of LDL-C in moderate-risk and low-risk groups in Korean adults.PMID:36727164 | DOI:10.4093/dmj.2021.0320
Source: Diabetes and Metabolism Journal - February 2, 2023 Category: Endocrinology Authors: Junghyun Noh Min Kyong Moon Eun-Jung Rhee Sang Hyun Park Hyeon Chang Kim Byung Jin Kim Hae Jin Kim Seonghoon Choi Jin Oh Na Young Youl Hyun Bum Joon Kim Kyung-Do Han In-Kyung Jeong Source Type: research

Cardiovascular Outcomes according to Comorbidities and Low-Density Lipoprotein Cholesterol in Korean People with Type 2 Diabetes Mellitus
CONCLUSION: For primary prevention of CVD in Korean adults with T2DM, it can be helpful to lower LDL-C targets when there are chronic kidney disease, HT, a long duration of diabetes mellitus, or three or more CV risk factors.PMID:36727163 | DOI:10.4093/dmj.2021.0344
Source: Atherosclerosis - February 2, 2023 Category: Cardiology Authors: Min Kyong Moon Junghyun Noh Eun-Jung Rhee Sang Hyun Park Hyeon Chang Kim Byung Jin Kim Hae Jin Kim Seonghoon Choi Jin Oh Na Young Youl Hyun Bum Joon Kim Kyung-Do Han In-Kyung Jeong Source Type: research

Association between Low-Density Lipoprotein Cholesterol Level and Cardiovascular Outcomes in Korean Adults: A Nationwide Cohort Study
CONCLUSION: We confirmed the incidence of CVD was increased in higher LDL-C range. The risk of CVD increased from ≥70 mg/dL of LDL-C in very high-risk and high-risk groups, and from ≥130 mg/dL of LDL-C in moderate-risk and low-risk groups in Korean adults.PMID:36727164 | DOI:10.4093/dmj.2021.0320
Source: Atherosclerosis - February 2, 2023 Category: Cardiology Authors: Junghyun Noh Min Kyong Moon Eun-Jung Rhee Sang Hyun Park Hyeon Chang Kim Byung Jin Kim Hae Jin Kim Seonghoon Choi Jin Oh Na Young Youl Hyun Bum Joon Kim Kyung-Do Han In-Kyung Jeong Source Type: research

Cardiovascular Outcomes according to Comorbidities and Low-Density Lipoprotein Cholesterol in Korean People with Type 2 Diabetes Mellitus
CONCLUSION: For primary prevention of CVD in Korean adults with T2DM, it can be helpful to lower LDL-C targets when there are chronic kidney disease, HT, a long duration of diabetes mellitus, or three or more CV risk factors.PMID:36727163 | DOI:10.4093/dmj.2021.0344
Source: Atherosclerosis - February 2, 2023 Category: Cardiology Authors: Min Kyong Moon Junghyun Noh Eun-Jung Rhee Sang Hyun Park Hyeon Chang Kim Byung Jin Kim Hae Jin Kim Seonghoon Choi Jin Oh Na Young Youl Hyun Bum Joon Kim Kyung-Do Han In-Kyung Jeong Source Type: research

Association between Low-Density Lipoprotein Cholesterol Level and Cardiovascular Outcomes in Korean Adults: A Nationwide Cohort Study
CONCLUSION: We confirmed the incidence of CVD was increased in higher LDL-C range. The risk of CVD increased from ≥70 mg/dL of LDL-C in very high-risk and high-risk groups, and from ≥130 mg/dL of LDL-C in moderate-risk and low-risk groups in Korean adults.PMID:36727164 | DOI:10.4093/dmj.2021.0320
Source: Diabetes and Metabolism Journal - February 2, 2023 Category: Endocrinology Authors: Junghyun Noh Min Kyong Moon Eun-Jung Rhee Sang Hyun Park Hyeon Chang Kim Byung Jin Kim Hae Jin Kim Seonghoon Choi Jin Oh Na Young Youl Hyun Bum Joon Kim Kyung-Do Han In-Kyung Jeong Source Type: research

Cardiovascular Outcomes according to Comorbidities and Low-Density Lipoprotein Cholesterol in Korean People with Type 2 Diabetes Mellitus
CONCLUSION: For primary prevention of CVD in Korean adults with T2DM, it can be helpful to lower LDL-C targets when there are chronic kidney disease, HT, a long duration of diabetes mellitus, or three or more CV risk factors.PMID:36727163 | DOI:10.4093/dmj.2021.0344
Source: Diabetes and Metabolism Journal - February 2, 2023 Category: Endocrinology Authors: Min Kyong Moon Junghyun Noh Eun-Jung Rhee Sang Hyun Park Hyeon Chang Kim Byung Jin Kim Hae Jin Kim Seonghoon Choi Jin Oh Na Young Youl Hyun Bum Joon Kim Kyung-Do Han In-Kyung Jeong Source Type: research